Bruker Corporation (BRKR)

Market Cap	6.56B
Revenue (ttm)	3.37B
Net Income (ttm)	113.10M
Shares Out	151.71M
EPS (ttm)	0.76
PE Ratio	56.97
Forward PE	16.14
Dividend	$0.20 (0.46%)
Ex-Dividend Date	Mar 17, 2025

Volume	1,927,296
Open	44.64
Previous Close	44.50
Day's Range	42.70 - 44.87
52-Week Range	42.70 - 94.64
Beta	1.18
Analysts	Buy
Price Target	68.40 (+58.3%)
Earnings Date	May 1, 2025

About BRKR

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 4, 2000
• Employees: 11,396
• Stock Exchange: NASDAQ
• Ticker Symbol: BRKR
• Website: https://www.bruker.com

Financial Performance

In 2024, Bruker's revenue was $3.37 billion, an increase of 13.56% compared to the previous year's $2.96 billion. Earnings were $113.10 million, a decrease of -73.53%.

Analyst Forecast

According to 12 analysts, the average rating for BRKR stock is "Buy." The 12-month stock price forecast is $68.4, which is an increase of 58.30% from the latest price.

Price Target

$68.4

(58.30% upside)

Analyst Consensus: Buy